Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSIF.L Regulatory News (SSIF)

  • There is currently no data for SSIF

Continuation Vote

27 Apr 2020 07:00

RNS Number : 8660K
SQN Secured Income Fund PLC
27 April 2020
Β 

SQN Secured Income Fund plc

(LSE: SSIF) (the "Company" or "SSIF")

Β 

Continuation Vote

The Board of SQN Secured Income Fund plc (LSE: SSIF), a specialist secured lending income generating investment trust, is pleased to provide an update on the Company's continuation vote due to be held this year.

As notified on 23 January, the Company's net asset value at the end of December 2019 was Β£50m which was below the Β£250m targeted when management of the Company's portfolio was assumed by SQN Asset Management Limited ("SQN"). Therefore, as required by the Company's Articles of Association, shareholders will be given the opportunity to decide on the Company's future by way of a continuation vote ("Continuation Vote").

Whilst the Board had planned to convene the Continuation Vote in Q1 2020, these plans were interrupted by the spread of Covid-19 which has since developed into a global pandemic with widespread lock downs. Consequently, the Board has resolved to convene a general meeting (the "General Meeting") to hold the Continuation Vote on 19th June 2020. The notice convening that General Meeting will be issued in mid/late May.

This decision has been taken after much debate as there are practical considerations to consider. The Board wants to ensure all shareholders have the opportunity to attend the General Meeting if possible, and to be fully consulted in advance of the General Meeting. Holding the General Meeting in June will, hopefully, allow for this.

Further, the Board thinks it prudent to wait until the outcome of the SQN Asset Finance Income Fund ("AFIF") investment manager review has concluded before consulting with shareholders and holding the General Meeting. The outcome of the review will almost certainly affect SSIF's current investment manager, SQN, albeit it should be noted that the AFIF management team is not the team that manages SSIF. The outcome of this review is expected by the end of this month.

In addition, the Board wishes to obtain a clearer view on the impact of Covid-19 on SSIF's portfolio before making any recommendation to shareholders. This applies to both the legacy portfolio and the more recent loans which SQN has originated and which, to date, are all performing in line with expectations with no missed payments.

The Board has been considering a wide range of options in relation to the Company's future. The economic stability of the assets and the preservation of capital and income is at the forefront of the Board's deliberations when reviewing these options, particularly given the current economic climate. Consequently, as previously announced, SSIF will not be advancing any new loans to new borrowers between now and the General Meeting.

Ken Hillen, Chairman of the Company, commented: "This short delay will hopefully allow for some clarity to be obtained on which the Board can make appropriate recommendations to shareholders, who in turn will have the opportunity to make an informed decision about the future of the Company."

Β For further information please contact:

SQN Asset Management Limited

Dawn Kendall

Β 

tel: +44 1932 575 888

Β 

finnCap Ltd.

Corporate Finance:

William Marle / Giles Rolls

Sales:

Mark Whitfeld

Β 

tel: +44 20 7220 0500

Β 

Β 

Β 

Β 

Β 

Kepler Partners LLP

Hugh van Cutsem

Β 

tel: +44 20 3384 8790

Buchanan Communications

Charles Ryland/Henry Wilson

Β 

tel: +44Β 20 7466 5000

Notes to Editor

The Company aims to provide shareholders with attractive risk-adjusted returns, principally in the form of regular, sustainable dividends, through investment predominantly in a range of secured loans and other secured loan-based instruments originated through a variety of channels and diversified by way of asset class, geography and duration.Β 

The Company's Investment Managers are SQN Capital Management, LLC, a Registered Investment Advisor with the United States Securities and Exchange Commission and its subsidiary, SQN Asset Management Limited. The principal responsible for managing the portfolio is Dawn Kendall.

This announcement contains Inside Information as defined under the Market Abuse Regulation (EU) No. 596/2014.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCEZLFLBZLZBBE
Date   Source Headline
2nd Aug 20238:19 amRNSDirector/PDMR Shareholding
1st Aug 202310:59 amRNSDirector/PDMR Shareholding
27th Jul 202312:00 pmRNSHolding(s) in Company
27th Jul 20239:45 amRNSDirector/PDMR Shareholding
25th Jul 202312:54 pmRNSNet Asset Value(s)
29th Jun 20237:00 amRNSB Share Scheme and Delisting
23rd Jun 20237:00 amRNSNet Asset Value(s)
30th May 20237:00 amRNSNet Asset Value(s)
22nd May 20234:45 pmRNSHolding(s) in Company
27th Apr 20237:00 amRNSNet Asset Value(s)
29th Mar 20234:35 pmRNSPrice Monitoring Extension
22nd Mar 20237:00 amRNSNet Asset Value(s)
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20237:00 amRNSHalf-year Report
15th Mar 202310:45 amRNSCancellation of Capital Redemption Reserve
13th Mar 20232:05 pmRNSSecond Price Monitoring Extn
13th Mar 20232:00 pmRNSPrice Monitoring Extension
8th Mar 20232:05 pmRNSSecond Price Monitoring Extn
8th Mar 20232:00 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSNet Asset Value(s)
30th Jan 20239:21 amRNSNet Asset Value(s)
29th Dec 20228:18 amRNSNet Asset Value(s)
15th Dec 20223:51 pmRNSResult of AGM and GM
6th Dec 20225:39 pmRNSHolding(s) in Company
29th Nov 20228:36 amRNSNet Asset Value(s)
23rd Nov 20225:27 pmRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSPublication of a circular
15th Nov 20227:00 amRNSNet Asset Value(s)
9th Nov 20221:24 pmRNSB Share Scheme
27th Sep 20228:48 amRNSNet Asset Value(s)
8th Sep 20224:00 pmRNSHolding(s) in Company
8th Sep 202210:00 amRNSAnnual Financial Report
2nd Sep 202212:00 pmRNSDividend Declaration
25th Aug 202210:00 amRNSNet Asset Value(s)
22nd Jul 20229:30 amRNSNet Asset Value(s)
11th Jul 20222:06 pmRNSSecond Price Monitoring Extn
11th Jul 20222:00 pmRNSPrice Monitoring Extension
11th Jul 202211:05 amRNSSecond Price Monitoring Extn
11th Jul 202211:00 amRNSPrice Monitoring Extension
29th Jun 20229:00 amRNSNet Asset Value(s)
6th Jun 20224:40 pmRNSSecond Price Monitoring Extn
6th Jun 20224:35 pmRNSPrice Monitoring Extension
6th Jun 20229:06 amRNSSecond Price Monitoring Extn
6th Jun 20229:00 amRNSPrice Monitoring Extension
26th May 20223:30 pmRNSB Share Scheme - Amendment
25th May 20224:53 pmRNSB Share Scheme
25th May 20229:00 amRNSNet Asset Value(s)
5th May 202212:00 pmRNSHolding(s) in Company
29th Apr 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.